Master Manufacturing Records and Batch Production Records: the heart of US supplement cGMP

If 21 CFR Part 111 has a centerpiece, it's the paperwork: the Master Manufacturing Record and the Batch Production Record. These two documents are where US supplement cGMP becomes concrete, and they're the first things an FDA inspector wants to see. Getting them right is the difference between passing and failing.

The Master Manufacturing Record

The MMR is the master recipe and method for a product at a given batch size: the complete formula, specifications, the exact procedures, in-process controls, and the testing required. Part 111 requires an MMR for each unique formulation and batch size. It is the controlled, approved blueprint every batch must follow.

The Batch Production Record

The BPR is the executed record of an actual batch made by following the MMR: the real quantities used, the lots of each ingredient, who did what and when, the in-process and finished results, and the quality control disposition. Where the MMR says what should happen, the BPR proves what did happen.

Why they have to match

The MMR and BPR work as a pair: the BPR demonstrates that a specific batch was made in accordance with the approved MMR and met its specifications. Discrepancies between intended and actual — unexplained deviations, missing signatures, results outside spec without resolution — are exactly what inspectors flag.

Why version control is everything

Formulas change — a supplier swap, a reformulation, a new overage. Each change should produce a new controlled MMR version, with batch records tied to the version they were made under. Managing this by hand across a catalog is error-prone; keeping MMRs and their versions structured and linked to every batch is what makes the system auditable.

This is general information, not regulatory or legal advice. US requirements change and turn on specifics, so confirm the current rules with the FDA, FTC, or a qualified US regulatory expert before relying on them.

Where Lemoniq fits

Lemoniq holds each product as one structured formula — ingredients, amounts, specifications, sourcing, and the documentation behind them — and generates what US dietary supplement manufacturing needs from that single source: the Supplement Facts panel, the claim and disclaimer wording, the records that cGMP expects, and the data to back overages, dating, and origin. Compliance becomes a property of the formula, not a pile of separate documents.

The takeaway

The US supplement model trades pre-market approval for full manufacturer responsibility, which means the work shifts onto documentation, accurate labeling, and defensible formulas. The brands that scale in the US are the ones whose single source-of-truth formula generates each label, specification, and record correctly — every time, across every product.

Lemoniq turns one formula into compliant, US-ready outputs — panel, claims, specs, and documentation — from a single source. We solve this exact problem. See how it works